Processed Red Meat Intake Linked to Increased Incidence of AML/MDS
Processed red meat intake is associated with an increased incidence of AML and MDS in a Japanese population, a study suggests.
Diagnosis & Disease Information
Chest CT Prior to Allo-HSCT Deemed Beneficial for Spotting Abnormalities
Patients with abnormal chest CTs had worse overall survival, nonrelapse mortality, and pulmonary-related death after allo-HSCT.
ICC Recategorization Facilitates Risk Stratification of Myelodysplastic Syndrome
A distinct mutational landscape and worse outcomes were seen for patients with MDS/AML vs those with MDS.
Posoleucel Deemed Effective Against Viral Infections in Allogeneic HSCT Recipients
Posoleucel appears safe and effective for treating refractory viral infections occurring after allogeneic hematopoietic stem cell transplant.
Blood Supply Shortages Delay Transfusions for MDS Patients
Blood supply shortages can delay transfusions by an average of 4 days for patients with myelodysplastic syndromes, a survey suggests.
Registry Data Quantify 5-Year Survival in Lower-Risk MDS
About 40% of patients with lower-risk myelodysplastic syndromes die of the disease within 5 years, a study suggests.
Lenalidomide Associated With Second Primary Malignancies in MM, Not Other Cancers
Lenalidomide increases the risk of developing a second primary malignancy in patients with multiple myeloma, a meta-analysis suggests.
Though Improved, Outcomes Remain Poor for Patients With MDS Who Progress on HMA Therapy
Researchers sought to determine outcomes in patients with MDS whose disease progressed during treatment with hypomethylating agents.
Venetoclax Plus Azacitidine Appears Promising in High-Risk MDS, CMML
Researchers sought to determine whether azacitidine plus venetoclax would be effective in patients with high-risk MDS or chronic myelomonocytic leukemia.
Integrating KMT2A-PTD into DNA NGS to Predict Outcomes in AML, MDS
Integrating the assessment of KMT2A-PTD into standard DNA sequencing may be prognostically valuable for patients with MDS or AML.
- Loading...
Loading...
Next post in Hematologic Cancers
Loading... 
Loading...